|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Myositis Specific 11 Ab Panel
Test Code71334
CPT Codes
PROF
Includes
Jo-1 Ab, PL-7 Ab, PL-12 Ab, EJ Ab, OJ Ab, SRP Ab, Mi-2 Alpha Ab, Mi-2 Alpha Ab, Mi-2 Beta Ab, MDA-5 Ab, TIF-1y Ab, NXP-2 Ab
Preferred Specimen
0.5 mL (0.3 mL minimum) serum
Transport Container: Plastic leak-proof container
Transport temperature: Room temperature
Transport Container: Plastic leak-proof container
Transport temperature: Room temperature
Minimum Volume
0.3 mL
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 28 days
Refrigerated: 14 days
Frozen: 28 days
Methodology
Line Blot
Setup Schedule
Set up: Tues-Sat; Report available: 4 days
Report Available
4 days
Reference Range
Jo-1 Ab | <11 SI |
PL-7 Ab | <11 SI |
PL-12 Ab | <11 SI |
EJ Ab | <11 SI |
OJ Ab | <11 SI |
SRP Ab | <11 SI |
Mi-2 Alpha Ab | <11 SI |
Mi-2 Beta Ab | <11 SI |
MDA-5 Ab | <11 SI |
TIF-1y Ab | <11 SI |
NXP-2 Ab | <11 SI |
Clinical Significance
Myositis-specific autoantibodies (MSAs) are highly selective, usually exclusive and are associated with particular clinical phenotypes within the myositis spectrum. Myositis-specific autoantibodies to cytoplasmic enzymes that catalyze the binding of specific amino acids to their cognate tRNA define the anti-synthetase syndrome characterized by myositis and lung inflammation, and include autoantibodies to Jo-1 (antihistidyl-tRNA synthetase), PL-7 (threonyl), PL-12 (alanyl), EJ (glycyl), and OJ (isoleucyl). A further subset of myositis patients is characterized by the presence of autoantibodies directed against the signal recognition particle (SRP). Autoantibodies to Mi-2 (Mi-2/nucleosome remodelling and deacetylase (NuRD) complex) are detected in patients with hallmark dermatomyositis features. Autoantibody to a cytoplasmic 140-kDa protein, melanoma-differentiation associated gene 5 (MDA5), also known as anti-CADM140, identified patients with clinically amyopathic dermatomyositis (CADM) and rapidly progressive lung disease. Autoantibodies to transcriptional intermediary factor 1-gamma (TIF-1 y), a p155/140 nuclear protein involved in cellular differentiation, have been reported in adult and juvenile dermatomyositis; in adults, it is associated with malignancy. Autoantibodies to nuclear matrix protein NXP-2, another 140-kDa protein, is found in juvenile dermatomyositis (JDM). Anti-TIF-1 y and anti-NXP-2, two novel serological subsets in JDM, occur collectively in >40% of children and appear to identify those with more severe disease.
Performing Laboratory
Quest Diagnostics Nichols SJC